In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.65% to 6,731.2 points.
Four shares that are climbing more than most today are listed below. Here's why they are storming higher:
Afterpay Ltd (ASX: APT)
The Afterpay share price is up 2% to $97.59. Investors have been buying Afterpay and other tech shares after a positive night of trade on the Nasdaq index. The tech-focused index outperformed the Dow Jones and S&P 500 with a 0.5% gain. This has led to the S&P/ASX All Technology Index (ASX: XTX) climbing 1.1% higher this morning.
Creso Pharma Ltd (ASX: CPH)
The Creso Pharma share price has continued its meteoric rise and is up 53% to 36 cents. Investors have been buying Creso Pharma's shares since the UN announced a landmark decision to reclassify cannabis as a less dangerous drug and the US House of Representatives voted to decriminalise cannabis. This morning it announced plans to expand into Canada's largest recreational market.
Healius Ltd (ASX: HLS)
The Healius share price is up 5% to $3.81. The catalyst for this has been the release of a strong trading update and the announcement of a $200 million on-market share buyback. The healthcare company also revealed that it has revised its dividend payout ratio to a target of 50% to 70% of reported net profit after tax.
Resonance Health Limited (ASX: RHT)
The Resonance Health share price has rocketed 51.5% higher to 23.5 cents. Investors have been fighting to get hold of the medical imaging company's shares after the US FDA approved its HepaFat-AI product. HepaFat-AI is a medical software that is fully automated and uses artificial intelligence to assess liver fat through the analysis of MRI datasets. This provides doctors with a comprehensive, multi-metric tool for use in the assessment of fatty liver.
